trending Market Intelligence /marketintelligence/en/news-insights/trending/cjY6ZLCof98vCUF8DjxjMQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In This List

Gilead promotes executive to replace outgoing CFO

S&P Global Market Intelligence

Cannabis Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Gilead promotes executive to replace outgoing CFO

Gilead Sciences Inc. named Andrew Dickinson its new CFO, replacing Robin Washington, effective Nov. 1.

Dickinson has been with the company since 2016 and is executive vice president, corporate development and strategy. He will continue with the role after he becomes CFO, Gilead said in an Oct. 15 release.

The executive led Gilead's 2017 acquisition of Kite Pharma Inc., and the $5.05 billion research collaboration with Galapagos NV that was announced in July, the company said. Dickinson served as global co-head of healthcare investment banking at Lazard Frères & Co. before joining Gilead.

Washington will remain with the company in an advisory capacity until early 2020 and will work with Dickinson during the transition.